Skip to site menu Skip to page content

GMP-Validated Adventitious Virus Testing by Next-Generation Sequencing

By IDT Biologika
Safety, quality, and efficacy of biologics are the basis for approving and authorising through state regulatory bodies. Safety is ensured among other activities by quality controls during the manufacturing process. This also includes testing for unwanted agents which pose a threat to human health. This safety control step is called Adventitious Agent Testing. Here, we specifically deal with viral contamination and name this topic Adventitious Virus Testing (AVT). This whitepaper provides you with required knowledge related to the involved regulatory authorities and scientific technologies and disciplines: Next Generation Sequencing (NGS), Bioinformaticsand Computer System Validation (CSV). Before starting, let us take a look at the history of AVT, which was not a matter of course.
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content